| Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... bmj 369, 2020 | 3558 | 2020 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... bmj 370, 2020 | 1087 | 2020 |
| Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ... British Medical Journal 2020, 2020 | 1087 | 2020 |
| Characterising Long Covid: a living systematic review M Michelen, L Manoharan, N Elkheir, V Cheng, D Dagens, C Hastie, ... BMJ Global Health, 2021 | 912 | 2021 |
| Characterising long term Covid-19: a living systematic review M Michelen, V Cheng, L Manoharan, N Elkheir, D Dagens, C Hastie, ... MedRxiv, 2020.12. 08.20246025, 2021 | 912* | 2021 |
| Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study O Swann, K Holden, L Turtle, L Pollock, C Fairfield, T Drake, S Seth, ... | 745* | 2020 |
| Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ... bmj 370, 2020 | 740 | 2020 |
| Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol A Docherty, E Harrison, C Green, H Hardwick, R Pius, L Norman, ... | 435 | 2020 |
| ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ... BMJ 369, m1985, 2020 | 417 | 2020 |
| Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study IM Osmanov, E Spiridonova, P Bobkova, A Gamirova, A Shikhaleva, ... medRxiv, 2021 | 348* | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe, 2021 | 330 | 2021 |
| Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol L Sigfrid, TM Drake, E Pauley, EC Jesudason, P Olliaro, WS Lim, ... medRxiv, 2021 | 327 | 2021 |
| Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia YM Arabi, AH Hajeer, T Luke, K Raviprakash, H Balkhy, S Johani, ... Emerging infectious diseases 22 (9), 1554, 2016 | 317 | 2016 |
| Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol Y Arabi, H Balkhy, AH Hajeer, A Bouchama, FG Hayden, A Al-Omari, ... Springerplus 4 (1), 1-8, 2015 | 253 | 2015 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 237 | 2021 |
| Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19 RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... medRxiv, 2020 | 237* | 2020 |
| Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID‐19 D Munblit, P Bobkova, E Spiridonova, A Shikhaleva, A Gamirova, ... Clinical & Experimental Allergy, 2021 | 205 | 2021 |
| Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial J Dunning, F Sahr, A Rojek, F Gannon, G Carson, B Idriss, T Massaquoi, ... PLoS medicine 13 (4), e1001997, 2016 | 195 | 2016 |
| Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial G Carson, B Idriss PLOS Medicine 1, 19, 2016 | 195* | 2016 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The lancet Respiratory medicine, 2021 | 179 | 2021 |
